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ABSTRACT
Knowledge about epidemiological distribution patterns of HIV infection in different 
geographic regions is relevant to understand the dynamics of the disease in Brazil. This 
study aims to characterize the epidemiological and clinical profile of HIV-infected patients 
from Southwestern Goias State, from 2005 to 2015. A standardized questionnaire was used 
to collect clinical-epidemiological, virological, and immunological data from the medical 
records of all HIV-infected patients (n=539) who were followed at the regional reference 
center of Jatai, Goias State, Brazil, from 2005 to 2015. We detected the prevalence of male 
patients and the heterosexual route of transmission, as well as an expressive number of 
young women infected with HIV. The HIV infection was more prevalent in reproductive 
ages (55.3%). Most patients presented clinical manifestations related to HIV infection at the 
time of diagnosis. Twenty-four patients presented coinfection with hepatitis C virus, syphilis, 
hepatitis B virus, leprosy or Chagas disease. Pneumonia caused by Pneumocystis jirovecii 
was the most common opportunistic infection, followed by neurotoxoplasmosis, tuberculosis, 
and neurocryptococcosis. Combined antiretroviral therapy improved CD4+ T-cell counts: 
the mean CD4+ T-cell counts after treatment was twice as high as those found at the first 
medical appointment; and highly active antiretroviral therapy promoted viral suppression in a 
significant number of patients. Considering the increasing distribution of HIV infection to the 
interior of Brazil, this descriptive study outlines the clinical-epidemiological characteristics 
of HIV infection in Southwestern Goias and contributes to develop local prevention strategies 
and public service plans.
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INTRODUCTION
The Joint United Nations Program on HIV/AIDS (UNAIDS) estimates that 
there are about 36.7 million people living with HIV/AIDS around the world1. In 
Brazil, 842,710 HIV/AIDS cases were reported from the beginning of the epidemic 
up to June 2016. Although high, the incidence rate stabilized at 19.1 cases/100,000 
inhabitants in Brazil in 20152. The incidence rate of HIV/AIDS markedly differs 
among Brazilian regions: it has been growing linearly in the North, Northeast and 
South regions; it has been declining in the Southeast region; and it is stable in the 
Midwest region. In the latter region, the incidence rate varied from 17.3 in 2005 to 
18.5 cases per 100,000 inhabitants in 20152.
The scenario has changed over the last years because the incidence of HIV 
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infection has shifted from metropolitan centers to the interior 
of the country and has become more prevalent among 
individuals with low income and poor education level. In 
other words, the current scenario reflects interiorization 
and pauperization of the disease3-6. Several studies have 
described the epidemiological profile of HIV infection 
in patients living in the main Brazilian urban centers, but 
there are limited data about its incidence rate in inner cities 
of the country, especially in Midwestern Brazil7-9. In this 
region, Goias State holds the highest number of cases of 
HIV infection: 1,004 cases were recorded in 2015, with an 
incidence rate of 15.2 cases/100,000 inhabitants. Although 
prevalent in heterosexual males, HIV infection among men 
who have sex with men (MSM) and heterosexual females 
is increasing2,10.
Goias State is divided into five macroregions (Northeast, 
Midwest, North-central, Southeast and Southwest); each 
one has a regional reference center responsible for providing 
diagnosis, treatment, and care to local HIV-infected patients. 
The regional center from Southwestern Goias is located in 
Jatai, a medium-sized city with 94,890 inhabitants that is 
320 km far from the capital, Goiania. Jatai hold one of the 
first four positions in the ranking of number of HIV-infected 
individuals in cities with more than 50,000 inhabitants in the 
Goias State from 2009 to 2012. The incidence rate is greater 
than the national rate, ranging from 20.5 to 21.1 infected 
individuals per 100,000 inhabitants, and the number of 
deaths associated with AIDS has increased since 201011-13.
Considering the interiorization and pauperization of 
the HIV epidemic, the knowledge of epidemiological 
distribution patterns of the disease in different Brazilian 
regions is relevant to understand the dynamics of the HIV 
epidemic, as well as to develop prevention strategies and 
public service plans. In this sense, the present study aims 
to characterize the clinical and epidemiological profile of 
HIV-infected patients who were assisted at the regional 
health center of Jatai, a city from Southwestern Goias State, 
in the Midwest region of Brazil, from 2005 to 2015.
MATERIAL AND METHODS
This is a descriptive study of HIV-infected outpatients 
followed-up at the Clinical Hospital Doutor Serafim de 
Carvalho (Jatai, Goias State, Brazil), which is the main 
public hospital from Southwestern Goias and a regional 
reference center for treatment of patients with infectious 
diseases. The local Research Ethics Committee approved 
the study protocol (UFG Nº 926.441 and 1.009.763).
Data were collected from medical records of patients 
diagnosed with HIV from 2005 to 2015, who were 
assisted at the aforementioned hospital. The researchers 
used a standardized questionnaire to collect the following 
information from the records: sociodemographic [age, 
gender, race/ethnicity (black, white, and mixed ethnicity); 
sociobehavioral (possible HIV exposure and sexual 
orientation - heterosexual, homosexual or bisexual); and 
clinical information (clinical manifestations at diagnosis, 
opportunistic infections, coinfections, deaths and the use 
of combined antiretroviral therapy - cART)].
The baseline CD4+ T-cell count and plasma viral 
load (PVL) quantification were the outcomes of interest 
to examine the immunological and virological status, 
respectively, of the patients at the moment of their first 
medical appointment at the hospital. The first and last CD4+ 
T-cell counts and PVL quantification were selected only 
for those patients undergoing cART. The lower and upper 
limits of detection of PVL were 50 and 500,000 copies/mL, 
respectively (Versant HIV-1 RNA 3.0 Assay, branched-
chain DNA, Bayer, Tarrytown, NY, USA). 
Data were analyzed using the Stata Data Analysis 
and Statistical Software version 12.0 (StataCorp. 2011. 
Stata Statistical Software: Release 12. College Station, 
TX, USA). The profile description of the parameters was 
reported by using mean and standard deviation (SD) to 
continuous variables, as well as frequency and percentage 
of categorical variables. Selected variables were compared 
between subjects with and without medical records using 
the chi-square test and the Student’s t test for categorical 
and continuous variables, respectively. Values of p < 0.05 
were considered statistically significant.
RESULTS
We examined the medical records of 539 patients 
with positive serology for HIV, who were assisted at a 
regional reference hospital in Jatai from 2005 to 2015. 
Analysis of the epidemiological profile (Table 1) revealed 
that the patients’ mean age was 39.5 years (SD: 11), with 
the predominance of men (57.9%), age group from 20 to 
40 years (54.2%), and the mixed self-declared ethnicity 
(57.1%). Stratification of the groups by gender confirmed 
the highest incidence rate among 20-40 year-old male and 
female patients: 55.1% and 50%, respectively. Only 6.7% 
of the patients were diagnosed before 2000; most of them 
(70%) were diagnosed within the last ten years (2006-2015).
Regarding the possible route(s) of HIV infection, 494 
patients (97.4%) reported unprotected sex; 4 patients 
reported unprotected sex and/or sharing syringes during 
intravenous drug use; 3 patients reported unprotected sex 
and/or blood transfusion and 6 patients reported mother-
to-child transmission. Most patients (82.4%) informed 
heterosexual orientation among male and female patients 
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Table 1 - Sociodemographic, behavioral, and laboratory data of HIV-infected patients from Jatai, Goias State, Brazila
Parameter Total records (n= 539)
Incomplete records 
(n= 170)
Complete records 
(n= 369)
Categorical variables n (%) n (%) n (%) p-value1
Gender 0.293
Female 227 (42.1) 66 (38.8) 161 (43.6)
Male 312 (57.9) 104 (61.2) 208 (56.4)
Age (years)b 0.965
< 20 5 (1.1) 1 (1.1) 4 (1.1)
20 - 40 247 (54.2) 45 (51.7) 202 (54.7)
41- 60 190 (41.7) 38 (43.7) 152 (41.2)
>60 14 (3.1) 3 (3.5) 11 (3)
Race/Ethnicityc 0.544
White 160 (30.6) 49 (31.8) 111 (30.2)
Mixed ethnicity 298 (57.1) 83 (53.9) 215 (58.4)
Black 64 (12.3) 22 (14.3) 42 (11.4)
Route of Infectiond 0.159
Sexual 494 (97.4) 138 (96.5) 356 (97.8)
Sexual + IDU 4 (0.8) 0 (0) 4 (1.1)
Sexual + Hemotransfusion 3 (0.6) 2 (1.4) 1 (0.3)
Vertical Transmission 6 (1.2) 3 (2.1) 3 (0.8)
Sexual Orientatione 0.647
Heterosexual 413 (82.4) 114 (81.4) 297 (82.3)
Homosexual 64 (12.8) 18 (12.9) 46 (12.7)
Bisexual 26 (5.2) 8 (5.7) 18 (5.0)
HIV Diagnosisf 0.157
1984 - 2000 35 (6.7) 14 (8.9) 21 (5.7)
2001 - 2005 115 (21.9) 37 (23.4) 78 (21.2)
2006 - 2010 167 (31.8) 55 (34.8) 112 (30.4)
2011 - 2015 209 (39.7) 52 (32.9) 157 (42.7)
cART useg 0.001*
cART 400 (76.6) 102 (66.7) 298 (80.8)
Naïve 122 (23.4) 51 (33.3) 71 (19.2)
Follow-up <0.001§
Followed-up 395 (73.3) 27 (15.9) 368 (99.7)
Death 84 (15.6) 83 (48.8) 1 (0.3)
Transference 20 (3.7) 20 (11.8) 0 (0)
Abandonment 40 (7.4) 40 (23.5) 0 (0)
Continuous variables mean (SD) mean (SD) mean (SD) p-value2
Age (years)b 39.5 (11.0) 40.4 (11.2) 39.3 (11.0) 0.793
CD4+ T-cell count (cells/mm3) 0.01**
Baselineh 
Lasti
408.2 (354.3) 
625.2 (386)
329.4 (298.8) 
421.4 (382.8)
436.4 (368.4) 
677.9 (369.4)
0.001#† 
0.03##
PVL (copies/mL)
Baselinej 
Lastk
 
1,471,537 (2.91e+07) 
27,984.2 (95,037.1)
 
118,361.5 (189,930.3) 
62,753 (139,879.5)
 
1,918,899 (3.36e+07) 
19,092.2 (77441.78)
 
0.002¥ 
<0.001¥¥
Abbreviations: cART, combined antiretroviral therapy; IDU, intravenous drug use; PVL, plasma viral load. aThe patients were divided 
into the groups “complete records” and “incomplete records” according to the completeness of their medical records. Total records = 
complete records + incomplete records. There are missing data for: b83 patients; c17 patients; d32 patients; e38 patients; f13 patients; 
g17 patients; h38 patients with total and incomplete medical records; i101 and 80 patients with total and incomplete medical records, 
respectively; j52 and 49 patients with total and incomplete medical records, respectively; k102 and 81 patients with total and incomplete 
medical records, respectively. 1p-values refers to the chi-square test. 2p-values refers to the Student’s t test. *Statistically significant 
difference between the following groups: cART use: * incomplete vs. complete. Baseline CD4+ T-cell count: **total vs. complete; 
#incomplete vs complete. Last CD4+ T-cell count: ##total vs. complete; †total vs. incomplete; †incomplete vs. complete. Baseline PVL: 
¥total vs. incomplete. Last PVL: ¥¥incomplete vs. complete. Follow-up: §total vs. incomplete; ¥¥incomplete vs. complete.
Dias et al.
Rev Inst Med Trop São Paulo. 2018;60:e34Page 4 of 8
followed by homosexual (12.8%) and male bisexual 
(5.2%) orientation. At the time of evaluation, 400 patients 
were taking cART drugs and 122 patients were not (naïve 
patients); in the first group, seven women were undergoing 
or had completed the prophylactic therapy during pregnancy 
to prevent vertical transmission.
The most frequent complaint of HIV-infected patients 
was weight loss (18.4%), followed by fever (13.4%), diarrhea 
(11.1%), lymphadenomegaly (8.3%), oral moniliasis (6.3%), 
neurological disorders (3.5%), headache (2.8%), recurrent 
bacterial infection (2.6%), seborrheic dermatitis (2.4%), 
fatigue and oral lesions (2%), herpes zoster (1.8%). In a 
few cases, there were night sweats, genital and anal lesions, 
pneumonia, hepatomegaly, condilomatosis, viral meningitis 
and prurigo nodularis. Twenty-four patients presented 
coinfection with hepatitis C virus (n=9), syphilis (n=8), 
hepatitis B virus (n=3), leprosy (n=3), and Chagas disease 
(n=1). There was no information regarding the signs and 
symptoms for 131 patients (24.3%) (data not shown).
During the clinical course of the disease, 203 patients 
(37.7%) were admitted to the hospital due to opportunistic 
infections, especially pneumonia caused by Pneumocystis 
jirovecii (10.6%), neurotoxoplasmosis (9.3%), tuberculosis 
(5.2%), neoplasia and neurocryptococcosis (2.6%), oral 
moniliasis (2.4%), and histoplasmosis (1.3%). Other 
opportunistic infections such as atypical mycobacteriosis, 
disseminated cytomegalovirus infection, peripheral 
neuropathies, herpetic encephalitis, cutaneous and visceral 
leishmaniosis, isosporiasis and ocular toxoplasmosis were 
registered at lower frequencies.
Eighty-four out of the 539 patients (15.6%) died; 
most of them were male (n=51). The cause of death of 50 
patients (60%) were related to HIV infection, including 
pneumonia (caused by P. jirovecii), neurotoxoplasmosis, 
cryptococcosis, lymphoma, uterine cancer, Kaposi’s 
sarcoma, fulminant hepatitis, visceral leishmaniosis and 
tuberculosis. The death of 34 patients (40%) were attributed 
to other causes non-related to HIV infection, such as acute 
myocardial infarction, renal insufficiency, breast cancer, 
esophagus cancer, lung cancer, and external causes.
A total of 170 out of 539 patients (31.5%) did not present 
complete medical records at the end of this study, because 
they died during the study period (n=83), were transferred to 
health care centers located in other cities (n=20), abandoned 
the treatment or were lost from the follow-up (n=67). These 
records reported only the baseline laboratory data collected 
during the first medical appointment at the health assistance 
service under study, or some laboratory data collected 
during the medical follow-up.
However, it was observed that these subjects had similar 
characteristics to those who presented the medical records. 
Most of the parameters, (gender, age/stratified age, race/
ethnicity, route of infection, sexual orientation, and time of 
diagnosis) was not statistically significant between groups 
without and with medical records (Table 1)
Analysis of the immunological and virological status 
of the patients stratified by exposure to cART (Table 2) 
evidenced that the mean baseline CD4+ T-cell counts and 
PVL in cART-naïve patients were 773.1 cells/mm3 and 
61,107.85 copies/mL, respectively. The PVL ranged from 
1,000 to 100,000 copies/mL (62%) in most cART-naïve 
patients; was undetectable (< 40 copies/mL) in 4 patients 
Table 2 - Laboratory data of HIV-infected patients from Jatai, Goias State, Brazil, stratified by the use of combined antiretroviral 
therapy (cART)
Parameter cART 
n= 298 (80.8%)
Naive 
n= 71 (19.2%)
Continuous variables mean (SD) mean (SD) p-value1
CD4+ T-cell count (cells/mm3)
Baseline 
Last
 
356.2 (291.7) 
664.5 (369.9)
 
773.1 (458.6) 
n/a
 
<0.001*
PVL (copies/mL)
Baseline 
Last 
 
2,366,028 (3.74e+07) 
14,229.25 (63,681.05)
 
61,107.85 (142,672.2) 
n/a
0.140
Categorical variable n (%) n (%) n (%)
PVL stratification
(copies/mL)                                 < 1,000
1,001-10,000 
10,001-100,000 
> 100,000
First 
63 (21.1) 
57 (19.1) 
95 (31.9) 
83 (27.9)
Last 
243 (81.6) 
19 (6.4) 
21 (7.0) 
15 (5.0)
 
17 (23.9) 
21 (29.6) 
23 (32.4) 
10 (14.1)
Abbreviations: cART, combined antiretroviral therapy; n/a, not applicable; PVL, plasma viral load. *Statistically significant difference 
between the mean of baseline and last CD4+ T-cell count in the group of patients undergoing cART. 1 p-values refers to the Student’s 
t test.
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(5.6%); and was > 100,000 copies/mL in 10 patients 
(14.1%).
In the group of patients undergoing cART, the mean 
baseline levels of CD4+ T-cell count and PVL were 356.2 
cells/mm3 and 2,366,028 copies/mL, respectively. One 
hundred and seven patients (35.9%) presented CD4+ 
T-cell counts <500 cells/mm3. The mean last CD4+ T-cell 
counts and PVL were 664.5 cells/mm3 and 14,229.25 
copies/mL, respectively. Only the baseline and the last 
mean CD4+ T-cell counts in patients undergoing cART 
were significantly different from each other (p < 0.001). 
Thirty-three (11.1%) out of the 63 (21.1%) patients with 
the first PVL <1,000 copies/mL had viremia below the 
limit of detection, and 83 patients (27.9%) had the first 
PVL >100,000 copies/mL. After taking cART, 218 (73.2%) 
out of the 243 (81.6%) patients with the last PVL <1,000 
copies/mL had undetectable viremia, and only 15 patients 
(5%) remained with PVL >100,000 copies/mL.
Most patients (n=297; 97.4%) were taking cART 
consisting of two classes of antiretroviral drugs: a nucleoside 
reverse transcriptase inhibitor (NRTI) in combination with 
a non-nucleoside reverse transcriptase inhibitor (NNRTI) or 
a boosted protease inhibitor (PI). Three patients (1%) were 
receiving highly active antiretroviral therapy (HAART); two 
of them had already taken salvage therapy with integrase 
inhibitor.
DISCUSSION 
Southwestern Goias is an economically rich region with 
high gross domestic product. Its suitable relief, hydrography, 
and climate for agriculture and livestock make this region 
one of the main soybean, corn, sorghum, and sugarcane 
producers, as well as one of the main areas of livestock 
management in Brazil. These features have attracted several 
multinational companies, ethanol, biodiesel and ecodiesel 
industries, and many migrants from all over the country14.
The epidemiological and clinical profiles of HIV-
infected patients living in small and medium-sized 
municipalities are poorly described, contrasting with 
national studies that cover mostly the population living 
in large urban centers7-9. Considering the AIDS epidemic 
spreading to the interior of Brazil and the attractive prospect 
of Southwestern Goiás, it is important to better understand 
the HIV infection dynamics in this region to prevent and 
monitor its dissemination.
In Jatai, a medium-sized city from Southwestern Goias, 
the first case of HIV infection was reported in 1997 in a male 
patient. This city presented the highest incidence rate of HIV 
infection in the Goias State between 2009 and 201211-13. In 
line with data reported by the Brazilian Ministry of Health, 
the present study found the predominance of male patients 
infected with HIV through the heterosexual route due to 
unprotected intercourse2. We also detected an expressive 
incidence of HIV infection among young women (58.6%). 
The national rate of HIV infection among women increased 
from the beginning of the AIDS epidemic up to 2008, after 
which it decreased among women but raised among men. 
In Jatai, the male/female ratio was 0.9:1 in 2008 and 1.4:1 
during the study period15. In contrast to the national trend, 
the incidence of HIV infection among women is increasing 
in some cities of the interior of Brazil4,10,16.
Regarding the age group, the HIV infection was more 
prevalent in the reproductive ages (up to 40 years-old; 
55.3%), with few cases among males older than 60 years-old 
(3.1%). Other studies and the Brazilian Ministry of Health 
have also reported that the reproductive age group was the 
most commonly involved2,9,17,18. 
The elevated HIV infection rate among Brazilian 
60-69 year-old individuals is partially due to their increased 
sexual activity, which probably occur without protection19.
Our study reported the predominance of the heterosexual 
route of HIV transmission, followed by the homosexual 
route. Heterosexual route has markedly grown in almost all 
regions of Brazil, confirming the potential role that wedding 
plays in the transmission of HIV infection to heterosexual 
women. In addition, the incidence of HIV infection among 
MSM increased in Midwestern Brazil from 36.1% in 2004 
to 45.8% in 20133,9,20,21. However, the prevalence of HIV 
infection may be under- and overestimated among MSM/
bisexual and heterosexual patients, respectively, in the 
present study. The individuals tend to emphasize their 
heterosexual relationships due to fear of the persistent 
stigma and discrimination.
The incidence rate of HIV infection among intravenous 
drug users (IDU) in Southwestern Goias may also be 
underestimated. A previous study has reported expressive 
rates of HIV infection in this group of patients from the 
Midwest, Southeast, and South regions of Brazil, which 
support the idea that the supply and access to illicit drugs 
in these regions are common22. The prevalence of HIV 
infection among IDU in the Goias State is 2%9,18.
The geographic location of Jatai facilitates the access to 
illicit drugs and may directly influence the epidemiological 
profile of HIV infection in Southwestern Goias. Jatai is an 
important route of drug traffic because it is near the main 
highway from Southwestern Goias (BR-364) that reaches 
the States of Mato Grosso and Mato Grosso do Sul, which 
in turn border with Paraguay and Bolivia.
Despite the advances in HAART, HIV infection still 
causes hospitalization and death due to opportunistic 
infections and difficulties in diagnosing them. Opportunistic 
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infections affect the immune system of HIV-infected patients, 
impair the treatment, favor the disease progress to AIDS, 
and cause death23,24. Pneumonia caused by P. jirovecii 
was the most prevalent opportunistic infection identified 
in HIV-infected patients studied herein, followed by 
neurotoxoplasmosis, tuberculosis, and neurocryptococcosis; 
this finding corroborates literature reports25-29. Toxoplasmosis 
is the most common cause of focal neurological injuries in 
Brazilian HIV-infected patients25,26. Cryptococcosis, the main 
systemic mycosis in immunosuppressed patients, especially 
in the form of meningoencephalitis and tuberculosis 
are important causes of morbidity and mortality among 
HIV-infected patients27-29.
As the opportunistic infection primarily affects 
individuals with CD4+ T-cell counts lower than 
200 cells/mm3, the mean CD4+ T-cell counts of patients with 
and without opportunistic infection (255 and 423 cells/mm3, 
respectively) were significantly different. 
The mortality rate identified in this study (15.6%) was 
greater than that reported for Midwestern Brazil in 2015 
(4.7%). The gender-specific mortality rate was higher 
among men (60.7%), in agreement with national data2. The 
fact that nearly 60% of the deaths were associated with HIV 
infection demonstrates that the availability of ART alone is 
not sufficient to provide survival of HIV-infected patients; 
other factors such as late diagnosis, clinical manifestations 
that confuse the diagnosis of opportunistic infections and 
poor adherence to treatment may negatively impact the 
incidence of deaths associated with AIDS30,31.
Although the regional reference center for HIV care in 
Jatai complies with the goals of the National Program on 
Sexually Transmitted Infection from the Brazilian Ministry 
of Health,which recommends early diagnosis, universal 
cART prophylaxis/therapy and routine laboratory tests for 
monitoring HIV infection, the morbidity and mortality rates 
associated with HIV infection remain high, indicating the 
need to develop actions to prevent evolution of the disease 
to severe immunodeficiency and death. Several studies have 
reported that cART promotes immune status recovery and 
viremia reduction32,33. In our study, the mean CD4+ T-cell 
count after cART was twice as high as those detected in the 
first medical appointment. In addition, HAART promoted 
viral suppression in a significant number of patients.
The limiting factor of this study was that the method used 
to collect data from medical records failed to address the 
geographic and temporal profile of HIV infection in patients 
living in Southwestern Goias, during the study period (2005-
2015). However, the present study had an important strength, 
the large sample size that represented all HIV-infected 
patients who were assisted at the regional health center of 
Southwestern region of Goias State, from 2005 to 2015.
Considering the current scenario of interiorization of 
HIV infection in Brazil, this descriptive study outlined the 
clinical and epidemiological profile of HIV-infected patients 
from the interior of Goias State. Altogether, our findings 
help to understand the epidemiology of the disease and 
develop specific actions and plans to address the priority 
needs of HIV-infected patients.
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